IBIO
iBio, Inc.
1.10$
+1.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 61.1% | 57.9% | 72.1% | 54.5% | 47.7% | 38.2% | 31.7% | 41.9% | 79.1% | 82.9% | 90.0% | 93.0% | |
| 3.9% | 8.2% | 10.6% | 49.5% | 45.0% | 32.3% | 26.0% | 37.0% | 43.8% | 44.5% | 55.5% | 56.9% | |
| 3.9% | 8.2% | 10.6% | 49.5% | 45.0% | 32.3% | 26.0% | 37.0% | 77.3% | 81.8% | 87.1% | 88.8% | |
| – | 5.1% | 28.1% | 2.5% | – | 0.1% | – | 0.5% | 0.1% | 0.0% | 0.0% | 1.1% | |
| – | 41.9% | – | – | – | – | – | – | – | – | – | – | |
| 14.3% | 15.8% | 10.7% | 18.7% | 21.9% | 28.2% | 31.9% | 29.5% | 10.7% | 6.7% | 2.1% | 1.8% | |
| 64.9% | 73.0% | 50.4% | 25.8% | 27.6% | 36.0% | 40.4% | 35.8% | 12.7% | 12.2% | 9.7% | 13.5% | |
| 55.0% | 63.4% | 42.7% | 13.4% | 14.1% | 21.7% | 28.3% | 26.3% | 9.4% | 9.2% | 7.6% | 11.9% | |
| 35.7% | 41.2% | 27.1% | 3.3% | 3.9% | 4.2% | 7.5% | 5.6% | 1.9% | 0.8% | 0.6% | 0.6% | |
| 5.1% | 5.5% | 2.4% | 1.2% | 3.5% | 2.8% | 7.7% | 9.4% | 4.4% | 4.1% | 3.5% | 4.5% | |
| – | – | 1.6% | 2.7% | 2.9% | 3.0% | – | – | – | – | – | – | |
| 35.1% | 27.0% | 49.6% | 74.2% | 72.4% | 64.0% | 59.6% | 64.2% | 87.3% | 87.8% | 90.3% | 86.5% | |
| -782.1% | -890.3% | -610.3% | -1,092.2% | -1,296.4% | -1,485.0% | -1,712.1% | -1,432.9% | -526.8% | -538.8% | -413.2% | -368.5% | |
| 3.2% | 5.5% | 7.4% | 30.0% | 35.2% | 42.1% | 51.6% | 70.8% | 82.6% | 153.9% | 139.3% | 105.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.